about
Randomized, controlled trial of therapy interruption in chronic HIV-1 infectionMarginal structural models for comparing alternative treatment strategies in ophthalmology using observational data.Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand.Retinopathy and progression of CKD: The CRIC studyInterobserver agreement in clinical grading of vitreous haze using alternative grading scales.Photographic assessment of baseline fundus morphologic features in the Comparison of Age-Related Macular Degeneration Treatments TrialsAssociation between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study).The role of orbital ultrasonography in distinguishing papilledema from pseudopapilledemaDelayed patchy choroidal filling in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age.Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials.Tear osmolarity in Sjögren syndromeObstructive sleep apnea and central serous chorioretinopathy.Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjectsTear osmolarity and dry eye symptoms in diabetics.A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab.Effectiveness of medial rectus advancement alone or in combination with resection or lateral rectus recession in the management of consecutive exotropia.Retention of functional DC-NK cross-talk following up to 18 weeks therapy interruptions in chronically suppressed HIV type 1+ subjects.Computational analysis of the evolution of the structure and function of 1-deoxy-D-xylulose-5-phosphate synthase, a key regulator of the mevalonate-independent pathway in plants.Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients.HIV-1-Specific CD4+ T Cell Responses in Chronically HIV-1 Infected Blippers on Antiretroviral Therapy in Relation to Viral Replication Following Treatment InterruptionVisual Acuity Outcome over Time in Non-Infectious UveitisAssociation of secondhand tobacco smoke exposure during childhood on adult cardiovascular disease risk among never-smokersFactors Predictive of Remission of Chronic Anterior Uveitis
P50
Q24809608-5E35A75F-5E25-4423-938C-A17335F32793Q30652690-5D14ABEF-1329-478A-A1F5-14EC118D8692Q33676532-796420D6-7C4F-4311-80B8-A859F3860B4DQ33835766-9F434403-EE8A-4FDA-B60C-5F8D9EF7BCABQ34005672-F26FBCE2-B9A1-425B-B877-A1799C47BAA6Q34237495-C9F04498-CC3A-4B5A-937F-C3345B7DACBEQ34239669-15670AB5-099A-49C9-B0EC-B09F010640F8Q34718439-A5FC379E-B4B6-45D8-9747-7E5FBD93A465Q35192091-A03BAAEB-E5B0-4702-8344-714C4F7272CCQ35214189-1D6EEBDE-5EED-4A34-AF9B-D0D975FEECDDQ36247080-C2B00884-5DA5-496D-B09D-D58F36F9E443Q36859607-C33333D7-D4C7-490C-88FE-1B1391477F70Q37233673-E7510B6C-1D70-4B4F-B801-3770D8CF9B3DQ37349847-6BC0B785-FCAA-4877-9629-3F77EFC7BC2FQ37388340-F56216AC-2484-4F9C-94B6-D23229CA85A7Q37641850-C1B57501-3080-456C-9537-BCC29C976CB3Q37998878-C5987B67-3D93-435A-8D6D-863C38731858Q38155647-2548B742-A615-459A-9822-E2DC987F3FA2Q42360738-9120F3CA-F77C-400C-8298-91A8E69A2030Q44574616-4B02A790-D079-4427-BEA0-BF53C20EE61DQ45721885-C256F77E-169A-413E-8437-049ED28A96F3Q53914336-CA72AC3F-6C3F-4841-8349-03C63EE68C3FQ57080548-04DB8D84-ECFF-42DE-8A52-5981A318E930Q91841099-961BC6EC-6A73-4E68-90E4-81897DDE5B5EQ91866424-AFE0E445-88E4-4E4B-A1F0-DD290F8D1837Q92606658-D1C90CB2-A312-4484-B4E2-161178D109F5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Maxwell Pistilli
@ast
Maxwell Pistilli
@en
Maxwell Pistilli
@es
Maxwell Pistilli
@nl
Maxwell Pistilli
@sl
type
label
Maxwell Pistilli
@ast
Maxwell Pistilli
@en
Maxwell Pistilli
@es
Maxwell Pistilli
@nl
Maxwell Pistilli
@sl
prefLabel
Maxwell Pistilli
@ast
Maxwell Pistilli
@en
Maxwell Pistilli
@es
Maxwell Pistilli
@nl
Maxwell Pistilli
@sl
P108
P106
P21
P31
P496
0000-0002-4266-4150